Sunday, April 18, 2021 |

Johnson & Johnson To ‘Assume Full Responsibility’ Manufacturing Drug Substance For COVID Vaccine At Emergent BioSolutions

April 5, 2021
Johnson & Johnson is assuming full responsibility regarding the manufacturing of drug substance for its COVID-19 vaccine at Emergent BioSolutions in Baltimore, the company announced Saturday. This comes after quality control issues at Emergent BioSolutions ruined up to 15 million potential Johnson & Johnson vaccine doses. “Specifically, the Company is adding dedicated leaders for operations and quality, and significantly increasing the number of manufacturing, quality and technical operations personnel to work with the Company specialists already at Emergent,” Johnson & Johnson said.


Article Source: WJZ-TV

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.